Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

BACKGROUND: Two standard sets of criteria are used to evaluate the tumor response of hepatocellular carcinoma (HCC): RECIST (Response Evaluation Criteria in Solid Tumors) and modified RECIST (mRECIST). The purpose was to compare two tumor response evaluation criteria, RECIST version 1.1 and mRECIST,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sato, Yozo, Watanabe, Hirokazu, Sone, Miyuki, Onaya, Hiroaki, Sakamoto, Noriaki, Osuga, Keigo, Takahashi, Masahide, Arai, Yasuaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Informa Healthcare 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572665/
https://ncbi.nlm.nih.gov/pubmed/23167460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/03009734.2012.729104
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller